Concepedia

Publication | Closed Access

A RANDOMIZED, DOUBLE-BLIND TRIAL OF BASILIXIMAB IMMUNOPROPHYLAXIS PLUS TRIPLE THERAPY IN KIDNEY TRANSPLANT RECIPIENTS1,2

DOI

144

Citations

17

References

2001

Year

Claudio Ponticelli, Alexander Yussim, V. Cambi, Christophe Legendre, Gaetano Rizzo, Maurizio Salvadori, Delawir Kahn, Habib Kashi, K. Salmela, Lutz Fricke,
Transplantation

Abstract

Basiliximab in combination with cyclosporine, steroids, and azathioprine triple therapy was highly effective in reducing the incidence of acute renal allograft rejection without increasing the incidence of infections and other side effects.

References

YearCitations

Page 1